He et al., 2019 - Google Patents
Synthetic disaccharide standards enable quantitative analysis of stored heparan sulfate in MPS IIIA murine brain regionsHe et al., 2019
- Document ID
- 7957750915664313562
- Author
- He Q
- Trim P
- Lau A
- King B
- Hopwood J
- Hemsley K
- Snel M
- Ferro V
- Publication year
- Publication venue
- ACS Chemical Neuroscience
External Links
Snippet
Heparan sulfate (HS) is a complex polysaccharide from the glycosaminoglycan (GAG) family that accumulates in tissues in several neurological lysosomal storage diseases known as mucopolysaccharidosis (MPS) disorders. The quantitation of HS in biological samples is …
- 229920002971 Heparan sulfate 0 title abstract description 240
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| He et al. | Synthetic disaccharide standards enable quantitative analysis of stored heparan sulfate in MPS IIIA murine brain regions | |
| Sun et al. | Brain glycogen serves as a critical glucosamine cache required for protein glycosylation | |
| Boutin et al. | Tandem mass spectrometry multiplex analysis of glucosylceramide and galactosylceramide isoforms in brain tissues at different stages of Parkinson disease | |
| Kubaski et al. | Glycosaminoglycans detection methods: Applications of mass spectrometry | |
| Kalikanda et al. | Study of the stereoselectivity of 2-azido-2-deoxygalactosyl donors: remote protecting group effects and temperature dependency | |
| JP6693954B2 (en) | Determination of glycosaminoglycan levels by mass spectrometry | |
| Jones et al. | Heparin characterization: challenges and solutions | |
| Zähringer et al. | Structure and biological activity of the short-chain lipopolysaccharide from Bartonella henselae ATCC 49882T | |
| Chuang et al. | A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses | |
| Warda et al. | Isolation and characterization of heparan sulfate from various murine tissues | |
| Pomin | NMR chemical shifts in structural biology of glycosaminoglycans | |
| Dong et al. | Stereospecific ester activation in nitrite-mediated carbohydrate epimerization | |
| Uhlig et al. | Enzyme-assisted synthesis and structural characterization of the 3-, 8-, and 15-glucuronides of deoxynivalenol | |
| Shao et al. | Mass spectral profiling of glycosaminoglycans from histological tissue surfaces | |
| Lawrence et al. | Characterization of glycan substrates accumulating in GM1 Gangliosidosis | |
| Zappe et al. | State‐of‐the‐art glycosaminoglycan characterization | |
| TW200400351A (en) | Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders | |
| Mizumoto et al. | Highly sulfated hexasaccharide sequences isolated from chondroitin sulfate of shark fin cartilage: insights into the sugar sequences with bioactivities | |
| Dhamale et al. | Arylsulfatase K is the lysosomal 2-Sulfoglucuronate sulfatase | |
| Bandara et al. | Chemical synthesis of human milk oligosaccharides: lacto-N-hexaose Galβ1→ 3GlcNAcβ1→ 3 [Galβ1→ 4GlcNAcβ1→ 6] Galβ1→ 4Glc | |
| Wang et al. | High-throughput liquid chromatography–tandem mass spectrometry quantification of glycosaminoglycans as biomarkers of mucopolysaccharidosis II | |
| Wang et al. | Improving the sensitivity for quantifying heparan sulfate from biological samples | |
| Kieser et al. | Total chemical syntheses of the GM3 and F–GM3 ganglioside epitopes and comparative pre-clinical evaluation for non-Invasive imaging of oligodendrocyte differentiation | |
| Veraldi et al. | Structural features of heparan sulfate from multiple osteochondromas and chondrosarcomas | |
| Moh et al. | SSSMuG: Same Sample Sequential Multi-Glycomics |